|
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019 |
Mar 29 2019 |
49 |
Global |
$3,500.00 |
|
|
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2019 |
Mar 29 2019 |
96 |
Global |
$2,000.00 |
|
|
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2019 |
Mar 29 2019 |
55 |
Global |
$3,500.00 |
|
|
Scar - Pipeline Review, H1 2019 |
Mar 29 2019 |
82 |
Global |
$2,000.00 |
|
|
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019 |
Mar 29 2019 |
31 |
Global |
$3,500.00 |
|
|
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2019 |
Mar 29 2019 |
90 |
Global |
$2,000.00 |
|
|
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019 |
Mar 26 2019 |
44 |
Global |
$3,500.00 |
|
|
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2019 |
Mar 26 2019 |
46 |
Global |
$3,500.00 |
|
|
Candidiasis - Pipeline Review, H1 2019 |
Mar 26 2019 |
174 |
Global |
$2,000.00 |
|
|
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2019 |
Mar 26 2019 |
52 |
Global |
$2,000.00 |
|
|
Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H1 2019 |
Mar 26 2019 |
76 |
Global |
$3,500.00 |
|
|
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019 |
Mar 26 2019 |
46 |
Global |
$3,500.00 |
|
|
Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Pipeline Review, H1 2019 |
Mar 26 2019 |
44 |
Global |
$3,500.00 |
|
|
Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H1 2019 |
Mar 26 2019 |
96 |
Global |
$3,500.00 |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H1 2019 |
Mar 26 2019 |
97 |
Global |
$3,500.00 |
|
|
Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2019 |
Mar 26 2019 |
142 |
Global |
$2,000.00 |
|
|
Cryptococcosis - Pipeline Review, H1 2019 |
Mar 26 2019 |
53 |
Global |
$2,000.00 |
|
|
Coccidioidomycosis - Pipeline Review, H1 2019 |
Mar 26 2019 |
54 |
Global |
$2,000.00 |
|
|
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2019 |
Mar 26 2019 |
90 |
Global |
$3,500.00 |
|
|
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Pipeline Review, H1 2019 |
Mar 26 2019 |
55 |
Global |
$3,500.00 |
|
|
72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2019 |
Mar 26 2019 |
32 |
Global |
$3,500.00 |
|
|
Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H1 2019 |
Mar 26 2019 |
115 |
Global |
$3,500.00 |
|
|
Batten Disease - Pipeline Review, H1 2019 |
Mar 18 2019 |
76 |
Global |
$2,000.00 |
|
|
Urinary Incontinence - Pipeline Review, H1 2019 |
Mar 18 2019 |
73 |
Global |
$2,000.00 |
|
|
Diarrhea - Pipeline Review, H1 2019 |
Mar 18 2019 |
140 |
Global |
$2,000.00 |
|
|
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2019 |
Mar 18 2019 |
129 |
Global |
$2,000.00 |
|
|
Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H1 2019 |
Mar 18 2019 |
63 |
Global |
$2,000.00 |
|
|
Myocardial Infarction - Pipeline Review, H1 2019 |
Mar 18 2019 |
294 |
Global |
$2,000.00 |
|
|
Encephalomyelitis - Pipeline Review, H1 2019 |
Mar 18 2019 |
60 |
Global |
$2,000.00 |
|
|
Restenosis - Pipeline Review, H1 2019 |
Mar 18 2019 |
48 |
Global |
$2,000.00 |
|
